HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard B Lipton Selected Research

barbituric acid (barbiturate)

1/2019Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
7/2017Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
10/2013Effects of switching acute treatment on disability in migraine patients using triptans.
9/2013Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
2/2009Tracing transformation: chronic migraine classification, progression, and epidemiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard B Lipton Research Topics

Disease

194Migraine Disorders (Migraine)
10/2022 - 01/2002
100Headache (Headaches)
02/2022 - 01/2002
51Pain (Aches)
06/2022 - 01/2002
21Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2005
20Cognitive Dysfunction
01/2022 - 02/2005
18Nausea
01/2021 - 04/2010
14Headache Disorders (Headache Syndromes)
10/2022 - 07/2003
13Dementia (Dementias)
01/2022 - 02/2005
12Epilepsy (Aura)
01/2022 - 04/2005
8Obesity
08/2017 - 10/2006
6Hyperalgesia
10/2021 - 06/2009
6Inflammation (Inflammations)
11/2018 - 01/2011
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 05/2004
5Prescription Drug Overuse
11/2020 - 10/2006
4Dizziness (Lightheadedness)
06/2022 - 01/2011
4Migraine with Aura (Familial Hemiplegic Migraine)
01/2022 - 08/2005
4Stroke (Strokes)
01/2022 - 02/2010
4Dysgeusia (Parageusia)
01/2021 - 05/2018
4Hypertension (High Blood Pressure)
01/2019 - 07/2002
4Hyperacusis (Phonophobia)
05/2018 - 04/2010
4Photophobia (Light Sensitivity)
05/2018 - 04/2010
4Parkinson Disease (Parkinson's Disease)
10/2017 - 07/2006
4Primary Headache Disorders
04/2017 - 05/2005
4Fatigue
11/2014 - 02/2007
3Sleepiness
06/2022 - 04/2011
3Disease Progression
11/2021 - 02/2009
3Tension-Type Headache (Tension Headache)
10/2017 - 06/2010
3Insulin Resistance
01/2015 - 04/2006
2Asthma (Bronchial Asthma)
01/2021 - 07/2002
2Chronic Pain
10/2020 - 01/2009
2Partial Epilepsies (Epilepsy, Partial)
11/2019 - 01/2018
2Secondary Headache Disorders
01/2019 - 08/2013
2Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 11/2014
2Weight Loss (Weight Reduction)
03/2017 - 04/2011
2Myocardial Infarction
01/2017 - 02/2010

Drug/Important Bio-Agent (IBA)

35Tryptamines (Triptans)IBA
06/2022 - 01/2002
21Opioid Analgesics (Opioids)IBA
10/2021 - 05/2004
21Type A Botulinum Toxins (Botox)FDA Link
01/2021 - 06/2010
20Pharmaceutical PreparationsIBA
10/2022 - 09/2004
17Pain-FreeIBA
08/2021 - 11/2002
15Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
04/2022 - 04/2011
15Calcitonin Gene-Related PeptideIBA
02/2022 - 05/2007
14Biological ProductsIBA
01/2021 - 11/2007
13Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2013
12erenumabIBA
01/2022 - 01/2018
11Sumatriptan (Imigran)FDA LinkGeneric
01/2019 - 11/2002
10Monoclonal AntibodiesIBA
02/2022 - 01/2018
9ubrogepantIBA
04/2022 - 08/2016
9Caffeine (No Doz)FDA LinkGeneric
01/2022 - 07/2002
9preemptIBA
12/2020 - 06/2010
8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 09/2008
8Topiramate (Topamax)FDA LinkGeneric
11/2020 - 02/2007
7eptinezumabIBA
02/2022 - 11/2014
7rimegepant sulfateIBA
10/2021 - 01/2019
7fremanezumabIBA
04/2021 - 11/2015
6ApolipoproteinsIBA
11/2020 - 01/2015
6Analgesics (Analgesic Drugs)IBA
01/2019 - 07/2002
6BarbituratesIBA
06/2015 - 11/2008
5lasmiditanIBA
06/2022 - 12/2018
5C-Reactive ProteinIBA
05/2022 - 01/2011
5salicylhydroxamic acid (SHAM)IBA
01/2022 - 04/2010
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 04/2005
5SolutionsIBA
01/2021 - 11/2010
5TabletsIBA
01/2019 - 10/2012
5barbituric acid (barbiturate)IBA
01/2019 - 02/2009
4galcanezumabIBA
01/2022 - 09/2018
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2019
4Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022 - 03/2006
4Indicators and Reagents (Reagents)IBA
01/2021 - 08/2017
4Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2020 - 01/2018
4PowdersIBA
01/2019 - 11/2010
3Polymethyl Methacrylate (Sol)IBA
01/2022 - 01/2020
3atogepantIBA
01/2022 - 01/2021
3Amyloid beta-PeptidesIBA
11/2021 - 05/2005
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2017
3Celecoxib (Celebrex)FDA Link
01/2021 - 01/2020
3Apolipoproteins E (ApoE)IBA
11/2020 - 01/2019
3Naproxen (Naprosyn)FDA LinkGeneric
04/2019 - 07/2010
3Nonprescription Drugs (Patent Medicines)IBA
10/2018 - 01/2005
3Ibuprofen (Motrin)FDA LinkGeneric
10/2017 - 03/2006
3Diclofenac (SR 38)FDA LinkGeneric
05/2017 - 02/2004
2CytokinesIBA
05/2022 - 01/2018
2Apolipoprotein E4IBA
01/2022 - 05/2016
2CholesterolIBA
10/2020 - 01/2019
2LipidsIBA
09/2019 - 01/2019
2Nasal SpraysIBA
01/2019 - 05/2018
2DFN-02IBA
01/2019 - 05/2018
2Hormones (Hormone)IBA
08/2017 - 07/2016
2Ergot AlkaloidsIBA
07/2017 - 01/2017

Therapy/Procedure

60Therapeutics
10/2022 - 01/2002
6Ambulatory Care (Outpatient Care)
06/2021 - 01/2012
6Autogenic Training
03/2021 - 12/2012
5Contraindications
06/2022 - 09/2013
4Aftercare (After-Treatment)
02/2022 - 04/2010
4Drug Therapy (Chemotherapy)
03/2021 - 05/2009
3Transcranial Magnetic Stimulation
01/2018 - 04/2010
3Injections
03/2015 - 06/2010
2Activities of Daily Living (ADL)
01/2022 - 10/2018
2Vagus Nerve Stimulation
01/2022 - 08/2016
2Psychology Biofeedback (Biofeedback)
10/2021 - 02/2011